BRIEF-Regeneron Pharma shares resume trading, up 16 percent

NEW YORK Wed May 1, 2013 11:17am EDT

NEW YORK May 1 (Reuters) - Regeneron Pharmaceuticals Inc : * Shares resume trading, up 16 percent * Shares as shares of Allergan slide after co says vision drug approval

likely delayed * Shares up 13.2 percent as shares of Allergan slide after co says

vision drug approval likely delayed

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.